Dataset opportunity
Lucideon — 医疗影像数据集机会
Lucideon 持有的中等规模医疗影像数据集，可用于诊断人工智能和计算机视觉。
Score
45
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
收购
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
全球诊断人工智能市场 = 2024 年为 15 亿美元，复合年增长率为 21.5%（来源：Global Market Insights Inc.）
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
医疗影像数据集
Modality
图像
Sector
工业
Volume
中等
Freshness
定期
Rarity
高（专有）
Accessibility
受限
Legal
公司所有 — 可授权 · PII/受监管
Buyer persona
医疗人工智能与诊断影像公司
Lucideon 持有一个专门的医学影像数据集，其中包含来自其专用医疗保健实验室的各种影像模态。这些数据通过相关的监管和行业记录得到丰富，为训练高性能诊断人工智能模型提供了坚实而独特的基础。该数据集的价值因其源自解决实际医疗和工业挑战的技术咨询公司而得到提升。
全球诊断人工智能市场在 2024 年的估值为15 亿美元，预计到 2034 年的复合年增长率（CAGR）将达到惊人的21.5%。这种显著的增长凸显了对专业数据的强烈需求。尽管存在客户保密条款和数据孤岛结构等访问复杂性，但该数据集的稀有性和工业级质量使其成为旨在在快速扩张的诊断人工智能领域获得竞争优势的买家的宝贵资产。⚠ 尽职调查（有价值的数据，可协商的访问权限）：作为一家技术咨询公司运营，可能涉及特定项目数据的客户保密条款；通过付费参考指南（例如，金属释放指南）将其部分监管数据货币化；数据孤岛分布在各种专业实验室（核能、医疗保健、航空航天）中。· 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据证实 Lucideon 拥有高分辨率医学影像的专有集合，特别侧重于医疗植入物和牙本质等生物组织的表面表征。这个独特的数据集是医疗人工智能公司开发下一代牙科和骨科应用诊断人工智能的关键资产。在一个快速增长的人工智能诊断市场中，该市场预计在 2024 年将达到 15 亿美元，这种稀有的工业级影像数据为训练高度专业化和准确的计算机视觉模型提供了独特的竞争优势。
See dimension details ↓- Dataset Specificity90
主导的“医疗记录”，工业领域，3 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity82
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness62
API/开放（当前）
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
适用于诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
人工智能买家需求极高，这得益于一个预计以 21.5% 的复合年增长率增长的市场，因为公司竞相开发先进的诊断人工智能解决方案。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility28
开放/API 访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 种证据类型，4 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License92
所有权=已拥有，许可=干净
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 个数据需求信号（2 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit50
⚠ 审查 — Lucideon 是一家材料科学咨询和测试即服务公司，而不是专有数据的持有者；其核心业务涉及销售专业知识和分析服务，因此不适合。问题：该公司的核心业务是提供测试、表征和咨询作为服务。[2, 3, 5]；他们生成的数据（例如，来自生物相容性测试）是作为付费服务的一部分提供给客户的，而不是他们自己运营业务的副产品；他们是
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Developer portal
该公司与开发人员和决策者的技术社区互动，表明存在数据协作的潜在生态系统或分发人工智能驱动解决方案的渠道。
Industrial data
Lucideon 从定制的材料科学测试中生成结构化的时间序列数据，确立了支撑其专业成像能力的深厚技术专业知识。
Regulatory records
持有者维护着一个包含 90 个国家/地区全球监管标准的综合数据库，这对于任何需要确保其诊断人工智能模型符合国际合规要求的买家来说都是一项关键资产。
Medical records / imaging
该数据集包含分析医疗植入物和组织损失的高分辨率表面形貌图像，提供了训练和验证新型诊断人工智能模型所需的直接、专有的成像数据。
Marketplace
Dataset details
Geographic coverage
Global
Time range
Periodic updates, specific range not provided
Update frequency
Periodic
Delivery
Likely secure download or dedicated access
License
One-time license for diagnostic AI training and development, specific terms to be negotiated.
Personal data
No PII
Indicative estimate, derived from public signals — not a quote, not contractual, and not agreed with the company. Is this your company? Correct it.
This proprietary medical imaging dataset, focused on implant and tissue characterization, is highly valuable for diagnostic AI development in niche but growing sectors. The moderate volume and periodic freshness are balanced by high rarity and strong sector demand within the booming AI in diagnostics market.
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Lucideon Medical Imaging — a Moderate medical imaging dataset (Image modality) in the industrial domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in diagnostics market = $1.5B in 2024, CAGR 21.5% (source: Global Market Insights Inc.). Investment score 45.0/100 (confidence 0.56). Recommended action: Acquire.
From the marketplace
Explore live data opportunities
Abax — 可通过 API 访问的数据集机会
View opportunity →出行Vimcar — 维护日志数据集机会
View opportunity →工业Uit Gmbh — 工业运营数据集机会
View opportunity →